Fundz Deep Dive
Everything you need to win scPharmaceuticals — in one platform.
Who to reach, what to say, and why now on scPharmaceuticals — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on scPharmaceuticals — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors
Aug 12, 2024•almost 2 years ago
Contract Type
partnership
MassachusettsBiotechnologyHealth CarePharmaceuticalDescription
scPharmaceuticals Inc. announced a partnership with Perceptive Advisors for non-dilutive financings totaling up to $125 million. This will be used to repay existing debt and fund activities related to the ongoing commercialization of FUROSCIX.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months